Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment - PubMed
Review
Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment
Clara Camaschella. Semin Hematol. 2009 Oct.
Abstract
Inherited sideroblastic anemia comprises several rare anemias due to heterogeneous genetic lesions, all characterized by the presence of ringed sideroblasts in the bone marrow. This morphological aspect reflects abnormal mitochondrial iron utilization by the erythroid precursors. The most common X-linked sideroblastic anemia (XLSA), due to mutations of the first enzyme of the heme synthetic pathway, delta-aminolevulinic acid synthase 2 (ALAS2), has linked heme deficiency to mitochondrial iron accumulation. The identification of other genes, such as adenosine triphosphate (ATP) binding cassette B7 (ABCB7) and glutaredoxin 5 (GLRX5), has strengthened the role of iron sulfur cluster biogenesis in sideroblast formation and revealed a complex interplay between pathways of mitochondrial iron utilization and cytosolic iron sensing by the iron-regulatory proteins (IRPs). As recently occurred with the discovery of the SLC25A38-related sideroblastic anemia, the identification of the genes responsible for as yet uncharacterized forms will provide further insights into mitochondrial iron metabolism of erythroid cells and the pathophysiology of sideroblastic anemia.
Similar articles
-
Pathophysiology and genetic mutations in congenital sideroblastic anemia.
Fujiwara T, Harigae H. Fujiwara T, et al. Pediatr Int. 2013 Dec;55(6):675-9. doi: 10.1111/ped.12217. Pediatr Int. 2013. PMID: 24003969 Review.
-
Bergmann AK, Campagna DR, McLoughlin EM, Agarwal S, Fleming MD, Bottomley SS, Neufeld EJ. Bergmann AK, et al. Pediatr Blood Cancer. 2010 Feb;54(2):273-8. doi: 10.1002/pbc.22244. Pediatr Blood Cancer. 2010. PMID: 19731322 Free PMC article.
-
Hereditary sideroblastic anemia: pathophysiology and gene mutations.
Harigae H, Furuyama K. Harigae H, et al. Int J Hematol. 2010 Oct;92(3):425-31. doi: 10.1007/s12185-010-0688-4. Epub 2010 Sep 17. Int J Hematol. 2010. PMID: 20848343 Review.
-
Recent advances in the understanding of inherited sideroblastic anaemia.
Camaschella C. Camaschella C. Br J Haematol. 2008 Oct;143(1):27-38. doi: 10.1111/j.1365-2141.2008.07290.x. Epub 2008 Jul 14. Br J Haematol. 2008. PMID: 18637800 Review.
-
Lee PL, Barton JC, Rao SV, Acton RT, Adler BK, Beutler E. Lee PL, et al. Blood Cells Mol Dis. 2006 Mar-Apr;36(2):292-7. doi: 10.1016/j.bcmd.2005.12.004. Epub 2006 Jan 30. Blood Cells Mol Dis. 2006. PMID: 16446107
Cited by
-
Mitochondrial ClpX Activates a Key Enzyme for Heme Biosynthesis and Erythropoiesis.
Kardon JR, Yien YY, Huston NC, Branco DS, Hildick-Smith GJ, Rhee KY, Paw BH, Baker TA. Kardon JR, et al. Cell. 2015 May 7;161(4):858-67. doi: 10.1016/j.cell.2015.04.017. Cell. 2015. PMID: 25957689 Free PMC article.
-
Sideroblastic anaemia in a patient with sickle cell disease.
Vobugari N, Chaturvedi M, Schlam-Camhi IM, Smith HP. Vobugari N, et al. BMJ Case Rep. 2022 Feb 8;15(2):e246623. doi: 10.1136/bcr-2021-246623. BMJ Case Rep. 2022. PMID: 35135795 Free PMC article.
-
Microcytic anemia in a pregnant woman: beyond iron deficiency.
Rollón N, Fernández-Jiménez MC, Moreno-Carralero MI, Murga-Fernández MJ, Morán-Jiménez MJ. Rollón N, et al. Int J Hematol. 2015 May;101(5):514-9. doi: 10.1007/s12185-014-1723-7. Epub 2014 Dec 30. Int J Hematol. 2015. PMID: 25547425
-
The Labile Side of Iron Supplementation in CKD.
Slotki I, Cabantchik ZI. Slotki I, et al. J Am Soc Nephrol. 2015 Nov;26(11):2612-9. doi: 10.1681/ASN.2015010052. Epub 2015 May 21. J Am Soc Nephrol. 2015. PMID: 25999405 Free PMC article. Review.
-
Recent advances in iron metabolism and related disorders.
Camaschella C, Strati P. Camaschella C, et al. Intern Emerg Med. 2010 Oct;5(5):393-400. doi: 10.1007/s11739-010-0387-4. Epub 2010 Apr 28. Intern Emerg Med. 2010. PMID: 20424932 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials